Immunomodulatory Profile of Dexmedetomidine Sedation in Patients Recovering After ARDS Covid-19

NCT04413864 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

SARS-CoV 2

Interventions

OTHER: Inflammatory cytokines and chemokines profiles of patients with dexmedetomidine administration

Sponsor

Assistance Publique - Hôpitaux de Paris